Literature DB >> 33178340

MBD2 and EZH2 regulate the expression of SFRP1 without affecting its methylation status in a colorectal cancer cell line.

Jun Yu1,2, Yang Xie1,2, Yuting Liu1,2, Feng Wang1,2, Mengying Li1,2, Jian Qi1,2.   

Abstract

Secreted frizzled-related protein 1 (SFRP1), which is an extracellular inhibitor involved in Wnt signalling, is downregulated by promoter hypermethylation in the early stages of colorectal tumorigenesis. Polycomb (PCG) and methyl-CpG-binding domain (MBD) proteins that serve a role in epigenetic gene regulation. The aim of the present study was to determine the role of PCG and MBD proteins in the regulation of SFRP1 gene expression in colorectal cancer (CRC), specifically in CRC cell lines and the human embryo intestinal mucosa cell line CCC-HIE-2. The methylation status of the SFRP1 gene promoter were analysed using methylation-specific PCR (MSP), whereas SFRP1 mRNA expression was analysed using reverse transcription-quantitative PCR. The association between PCG and MBD proteins and the SFRP1 gene was assessed, where associated proteins were screened by chromatin immunoprecipitation and their expression were subsequently knocked down using RNA interference to determine their role in the regulation of SFRP1 gene expression. The SFRP1 promoter was demonstrated to be hypermethylated in CRC cell lines and partially methylated in the non-cancerous cell line CCC-HIE-2. SFRP1 mRNA expression was significantly lower in CRC cell lines compared with that of CCC-HIE-2 cells. The expression of PCGs enhancer of zeste homolog 2 (EZH2) and BMI1, along with MBD2, was indicated to be upregulated with SFRP1 methylation in HCT116 and SW480 cells. The SFRP1 promoter region was enriched with EZH2 in CCC-HIE-2 cells and enriched with EZH2 and MBD2 in SW480 cells, whereas none of the proteins examined were indicated on the SFRP1 promoter in HCT116 cells. The expression of SFRP1 was reactivated by MBD2 small interfering (si)RNA but not by EZH2 siRNA in SW480 cells, but combined MBD2 and EZH2 knockdown effectively restored SFRP1 gene expression without affecting the methylation status of the SFRP1 promoter. In conclusion, data from the present study revealed that MBD2 and EZH2 regulated SFRP1 expression without affecting the hypermethylation of SFRP1 in CRC cell lines. Instead, the regulation of SFRP1 expression may be through a distinct mechanism, which warrants further investigation.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  DNA methylation; colorectal cancer; enhancer of zeste homolog 2; methyl-CpG-binding domain protein 2; secreted frizzled related protein 1

Year:  2020        PMID: 33178340      PMCID: PMC7651780          DOI: 10.3892/etm.2020.9372

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  33 in total

1.  MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase.

Authors:  K I Tatematsu; T Yamazaki; F Ishikawa
Journal:  Genes Cells       Date:  2000-08       Impact factor: 1.891

2.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

3.  An intrinsically disordered region of methyl-CpG binding domain protein 2 (MBD2) recruits the histone deacetylase core of the NuRD complex.

Authors:  Megha A Desai; Heather D Webb; Leander M Sinanan; J Neel Scarsdale; Ninad M Walavalkar; Gordon D Ginder; David C Williams
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

4.  Impact of cytosine methylation on DNA binding specificities of human transcription factors.

Authors:  Yimeng Yin; Ekaterina Morgunova; Arttu Jolma; Eevi Kaasinen; Biswajyoti Sahu; Syed Khund-Sayeed; Pratyush K Das; Teemu Kivioja; Kashyap Dave; Fan Zhong; Kazuhiro R Nitta; Minna Taipale; Alexander Popov; Paul A Ginno; Silvia Domcke; Jian Yan; Dirk Schübeler; Charles Vinson; Jussi Taipale
Journal:  Science       Date:  2017-05-05       Impact factor: 47.728

5.  lncRNA SNHG1 cooperated with miR-497/miR-195-5p to modify epithelial-mesenchymal transition underlying colorectal cancer exacerbation.

Authors:  Jinghui Bai; Jian Xu; Jian Zhao; Rui Zhang
Journal:  J Cell Physiol       Date:  2019-07-05       Impact factor: 6.384

6.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.

Authors:  Louis Vermeulen; Felipe De Sousa E Melo; Maartje van der Heijden; Kate Cameron; Joan H de Jong; Tijana Borovski; Jurriaan B Tuynman; Matilde Todaro; Christian Merz; Hans Rodermond; Martin R Sprick; Kristel Kemper; Dick J Richel; Giorgio Stassi; Jan Paul Medema
Journal:  Nat Cell Biol       Date:  2010-04-25       Impact factor: 28.824

Review 7.  Wnt signalling and its impact on development and cancer.

Authors:  Alexandra Klaus; Walter Birchmeier
Journal:  Nat Rev Cancer       Date:  2008-05       Impact factor: 60.716

Review 8.  Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation.

Authors:  Kathleen H Wood; Zhaolan Zhou
Journal:  Front Genet       Date:  2016-05-26       Impact factor: 4.599

Review 9.  The molecular hallmarks of epigenetic control.

Authors:  C David Allis; Thomas Jenuwein
Journal:  Nat Rev Genet       Date:  2016-06-27       Impact factor: 53.242

10.  Epigenetic and genetic features of 24 colon cancer cell lines.

Authors:  D Ahmed; P W Eide; I A Eilertsen; S A Danielsen; M Eknæs; M Hektoen; G E Lind; R A Lothe
Journal:  Oncogenesis       Date:  2013-09-16       Impact factor: 7.485

View more
  2 in total

Review 1.  The long and short non-coding RNAs modulating EZH2 signaling in cancer.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Kiavash Hushmandi; Farid Hashemi; Amirhossein Zabolian; Israel Canadas; Ali Zarrabi; Noushin Nabavi; Amir Reza Aref; Francesco Crea; Yuzhuo Wang; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  J Hematol Oncol       Date:  2022-03-02       Impact factor: 17.388

2.  Expression of Tumor Suppressor SFRP1 Predicts Biological Behaviors and Prognosis: A Potential Target for Oral Squamous Cell Carcinoma.

Authors:  Chun Chen; Yifei Zhang; Yupeng Liu; Lei Hang; Jun Yang
Journal:  Biomolecules       Date:  2022-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.